• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/15/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon rupture occurred.The target lesion was located in the moderately calcified superficial femoral artery.A 5.0 x 100mm, 80cm ranger paclitaxel-coated pta balloon catheter was selected for use.During the procedure, it was noted that the balloon ruptured upon first inflation at 6 atm for 10 seconds.The device was removed using normal method without issue and the procedure was completed with another of the same device.No complications were reported, and the patient was in good condition post procedure.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the device was returned for evaluation.The returned device was attached to a boston scientific encore inflation unit and the balloon was inflated to its rated burst pressure of 14 atmospheres with no leaks or issues noted.The markerbands and blades and tip section of the device were visually examined, and no issues were noted with the markerbands or tip of the device.A visual and tactile examination of the hypotube shaft found no issues with the shaft.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that balloon rupture occurred.The target lesion was located in the moderately calcified superficial femoral artery.A 5.0 x 100mm, 80cm ranger paclitaxel-coated pta balloon catheter was selected for use.During the procedure, it was noted that the balloon ruptured upon first inflation at 6 atm for 10 seconds.The device was removed using normal method without issue and the procedure was completed with another of the same device.No complications were reported, and the patient was in good condition post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18742101
Report Number2124215-2024-09934
Device Sequence Number12361387
Product Code ONU
UDI-Device Identifier08714729975991
UDI-Public08714729975991
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/23/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number04320H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/15/2024
Supplement Date Received by Manufacturer03/14/2024
Initial Report FDA Received Date02/20/2024
Supplement Report FDA Received Date03/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/24/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-